Page last updated: 2024-09-03
pentosidine and carnosine
pentosidine has been researched along with carnosine in 1 studies
Compound Research Comparison
| Studies (pentosidine) | Trials (pentosidine) | Recent Studies (post-2010) (pentosidine) | Studies (carnosine) | Trials (carnosine) | Recent Studies (post-2010) (carnosine) |
|---|---|---|---|---|---|
| 577 | 34 | 205 | 2,054 | 136 | 829 |
Protein Interaction Comparison
| Protein | Taxonomy | pentosidine (IC50) | carnosine (IC50) |
|---|---|---|---|
| Solute carrier family 15 member 2 | Homo sapiens (human) | 28 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Faraji, E; Houjeghani, S; Jafarabadi, MA; Kheirouri, S | 1 |
Trials
1 trial(s) available for pentosidine and carnosine
| Article | Year |
|---|---|
l-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor-α levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial.
Topics: Adipose Tissue; Adult; Arginine; Blood Glucose; Body Composition; Carnosine; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Fasting; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Triglycerides; Tumor Necrosis Factor-alpha | 2018 |